Validation of a Screening Test for Sarcopenia in Older People
Not Applicable
- Conditions
- Sarcopenia
- Registration Number
- NCT03196622
- Lead Sponsor
- University Hospital, Clermont-Ferrand
- Brief Summary
Identify the threshold which the handgrip strenght can be used as a screening test of sarcopenia.
Handgrip strenght can be used in daily clinical practice to screen patients having sarcopenia to improve treatment and quality of life.
- Detailed Description
A cross-sectional multicentre study will be performed in hospital and retirement houses on patients ages 75 years old or more.
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 1300
Inclusion Criteria
- ≥ 75 years old
Exclusion Criteria
- Palliative care,
- Protection of vulnerable adults
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Primary Outcome Measures
Name Time Method Handgrip test could be used as a screening test of sarcopenia at day 1
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms link handgrip strength to sarcopenia progression in elderly populations?
How does handgrip strength screening compare to DXA or BIA in sarcopenia detection accuracy?
Which biomarkers correlate with handgrip strength thresholds for sarcopenia diagnosis?
What adverse events are associated with handgrip strength-based sarcopenia interventions in clinical practice?
Are there combination therapies with handgrip strength assessment to enhance sarcopenia management in geriatric patients?
Trial Locations
- Locations (1)
CHU de Clermont-Ferrand
🇫🇷Clermont-Ferrand, Auvergne, France
CHU de Clermont-Ferrand🇫🇷Clermont-Ferrand, Auvergne, FrancePatrick LACARINContact04 73 75 11 95placarin@chu-clermontferrand.frMarie BLANQUETPrincipal Investigator